SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-286744
Filing Date
2021-09-29
Accepted
2021-09-29 16:06:05
Documents
12
Period of Report
2021-09-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K d217919d8k.htm   iXBRL 8-K 27957
  Complete submission text file 0001193125-21-286744.txt   151658

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20210923.xsd EX-101.SCH 2904
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20210923_lab.xml EX-101.LAB 18139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20210923_pre.xml EX-101.PRE 11416
5 EXTRACTED XBRL INSTANCE DOCUMENT d217919d8k_htm.xml XML 3382
Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 211291688
SIC: 2834 Pharmaceutical Preparations